體外膜氧合（ECMO）設備市場規模、佔有率和成長分析（按組件、模式、患者年齡層、應用、最終用戶和地區分類）—2025-2032年產業預測

全球體外膜氧合（ECMO）市場規模預計在 2023 年達到 3.114 億美元，從 2024 年的 3.2822 億美元成長到 2032 年的 4.999 億美元，在預測期（2025-2032 年）內複合年成長率為 5.4%。

隨著體外膜氧合（ECMO）這項關鍵技術在治療常規治療方法無效的嚴重心臟衰竭衰竭方面發揮至關重要的作用，全球ECMO設備市場正穩步成長。加護治療基礎設施的進步、心肺疾病盛行率的上升以及ECMO在臨床實踐中更廣泛的應用，都推動了市場需求的成長。諸如便攜性提升、生物相容性材料的使用以及整合監測系統等創新技術即將問世，這將進一步增強ECMO在緊急情況下的應用。專業ECMO中心的建立和訓練有素的多學科團隊的組成也推動了ECMO的進一步普及。然而，ECMO仍面臨許多挑戰，包括設備高成本、熟練專業人員短缺、ECMO管理複雜以及報銷和監管方面的不確定性，尤其是在新興市場，這些都可能阻礙ECMO的廣泛應用。

推動全球體外膜氧合（ECMO）市場發展的因素

全球體外膜氧合（ECMO）設備市場的主要促進因素之一是呼吸系統和心臟疾病的日益普遍，這些疾病需要先進的生命維持系統。急性呼吸窘迫症候群（ARDS）、心臟衰竭和重症肺炎等疾病發生率的上升，推動了醫療機構對ECMO技術的需求激增。此外，ECMO技術的進步，例如可攜式系統的改進和療效的提高，也促進了其在加護治療領域的應用。人們對ECMO在嚴重健康危機中挽救生命的益處的認知不斷提高，也顯著促進了市場的擴張。

全球體外膜氧合（ECMO）市場阻礙因素

全球體外膜氧合（ECMO）設備市場的主要阻礙因素是ECMO系統及其相關組件的高成本。採購、維護和營運所需的大量資金投入，對醫療機構而言構成重大障礙，尤其是在預算和資源有限的發展中地區。此外，缺乏能夠操作這些先進設備的訓練有素的醫護人員，也會阻礙ECMO的普及應用，導致其利用率不足。同時，監管方面的挑戰以及人力資源發展的複雜性，也構成了額外的障礙，可能會減緩全球各地不同醫療機構的市場成長和普及速度。

全球體外膜氧合（ECMO）市場趨勢

全球體外膜氧合（ECMO）設備市場正呈現出高度便攜、易於操作的系統發展的顯著趨勢。製造商致力於研發緊湊輕便的ECMO設備，使其能夠在傳統加護病房之外的場所使用，從而在規模較小的醫療機構和患者轉運過程中實現有效治療。這些進步縮短了設備安裝時間，提高了ECMO治療的可近性，尤其是在農村和資源匱乏的地區。隨著醫療機構日益重視設備的便攜性和易用性，市場正在轉型以滿足不斷變化的患者照護需求，最終改善臨床療效並提高營運效率。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境
• 原料分析

體外膜氧合（ECMO）設備市場規模（依組件分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 泵浦
• 氧合設備
• 控制器
• 套管和導管套裝
• 配件和耗材

體外膜氧合（ECMO）設備市場規模：依模式和複合年成長率（2025-2032 年）分類

• 市場概覽
• 靜脈-靜脈（VV）
• 靜脈-動脈（VA）
• 動靜脈（AV）

體外膜氧合（ECMO）設備市場規模：依病患年齡層及複合年成長率（2025-2032 年）分類

• 市場概覽
• 新生
• 孩子們
• 成人

體外膜氧合（ECMO）設備市場規模：依應用及複合年成長率（2025-2032）分類

• 市場概覽
• 呼吸系統疾病
• 心臟病
• 體外心肺復甦術（ECPR）

體外膜氧合（ECMO）設備市場規模（依最終用戶分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 醫院（加加護病房/心臟監護室）
• 專科診所
• 緊急醫療服務

體外膜氧合（ECMO）設備市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Medtronic plc
• Getinge AB
• LivaNova PLC
• Terumo Cardiovascular Corporation
• Nipro Corporation
• Eurosets Srl
• Maquet Holding（Getinge Group）
• CytoSorbents Corporation
• Medos Medizintechnik AG
• Microport Scientific Corporation
• Philips Healthcare（ECLS division）
• Edwards Lifesciences Corporation
• Xenios AG
• Saranas Inc.
• Oxygen Plus Medical Systems
• Hemovent GmbH
• Abiomed Inc.
• Boston Scientific Corporation
• Smiths Medical（ICU Life Support Division）
• Baxter International Inc.

結論與建議

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 311.4 million in 2023 and is poised to grow from USD 328.22 million in 2024 to USD 499.9 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The global market for extracorporeal membrane oxygenation (ECMO) machines is experiencing steady growth as this vital technology becomes integral in managing severe cardiac and respiratory failures when conventional treatments fall short. Factors fueling demand include advancements in critical care infrastructures, rising prevalence of cardiopulmonary diseases, and broader acceptance of ECMO in clinical practices. Innovations such as increased portability, use of biocompatible materials, and integrated monitoring systems are on the horizon, enhancing usability in emergency scenarios. The establishment of specialized ECMO centers and trained multidisciplinary teams is further propelling adoption. However, challenges remain, including the high costs of machines, a shortage of skilled professionals, complexities in managing ECMO, and uncertainties in reimbursement and regulation, particularly in emerging markets, which may hinder broader implementation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Extracorporeal Membrane Oxygenation Machine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Extracorporeal Membrane Oxygenation Machine Market

One of the key market drivers for the global extracorporeal membrane oxygenation (ECMO) machine market is the increasing prevalence of respiratory and cardiac diseases that require advanced life-support systems. As the incidence of conditions such as acute respiratory distress syndrome (ARDS), heart failure, and severe pneumonia rises, the demand for ECMO technology has surged in healthcare institutions. Additionally, advancements in ECMO technology, including improvements in portable systems and increased efficacy, have bolstered its adoption in critical care settings. This growing recognition of ECMO's role in saving lives during severe health crises significantly contributes to the expansion of the market.

Restraints in the Global Extracorporeal Membrane Oxygenation Machine Market

A significant restraint in the global extracorporeal membrane oxygenation (ECMO) machine market is the high cost of ECMO systems and their associated components. The substantial financial investment required for procurement, maintenance, and operation can be a major hurdle for healthcare facilities, particularly in developing regions with limited budgets and resources. Additionally, the shortage of trained healthcare professionals to operate these sophisticated machines can hinder their implementation, leading to underutilization. Furthermore, regulatory challenges and the complexity involved in training personnel pose additional barriers that could slow market growth and adoption rates across various healthcare settings worldwide.

Market Trends of the Global Extracorporeal Membrane Oxygenation Machine Market

The Global Extracorporeal Membrane Oxygenation (ECMO) Machine market is witnessing a significant trend toward the development of portable and user-friendly systems. Manufacturers are focusing on creating compact, lightweight ECMO machines that facilitate their use beyond traditional intensive care units, enabling effective treatment even in smaller healthcare facilities or during patient transport. These advancements lead to quicker setup times, thereby enhancing accessibility to ECMO therapy, particularly in rural and resource-limited environments. As healthcare providers increasingly prioritize mobility and ease of use, the market is transforming to meet the evolving needs of patient care, ultimately improving clinical outcomes and operational efficiency.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Raw Material Analysis

Global Extracorporeal Membrane Oxygenation Machine Market Size by Component & CAGR (2025-2032)

• Market Overview
• Pumps
• Oxygenators
• Controllers
• Cannula & Tubing Sets
• Accessories & Consumables

Global Extracorporeal Membrane Oxygenation Machine Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Veno-Venous (VV)
• Veno-Arterial (VA)
• Arterio-Venous (AV)

Global Extracorporeal Membrane Oxygenation Machine Market Size by Patient Age Group & CAGR (2025-2032)

• Market Overview
• Neonates
• Pediatrics
• Adults

Global Extracorporeal Membrane Oxygenation Machine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Respiratory Disorders
• Cardiac Conditions
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Global Extracorporeal Membrane Oxygenation Machine Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals (ICU / Cardiac Care Units)
• Specialty Clinics
• Emergency Medical Services

Global Extracorporeal Membrane Oxygenation Machine Market Size & CAGR (2025-2032)

• North America (Component, Modality, Patient Age Group, Application, End-User)
  • US
  • Canada
• Europe (Component, Modality, Patient Age Group, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Patient Age Group, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Patient Age Group, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Patient Age Group, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Cardiovascular Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet Holding (Getinge Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medos Medizintechnik AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microport Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (ECLS division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenios AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saranas Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxygen Plus Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abiomed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (ICU Life Support Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations